期刊文献+

TRB3在非诺贝特抑制高糖诱导的肾小球系膜细胞增殖中的作用及其机制 被引量:4

Role of TRB3 in the inhibitory effect of fenofibrate against high glucose-induced proliferation of glomerular mesangial cells
下载PDF
导出
摘要 目的探讨TRB3在非诺贝特抑制高糖诱导下肾小球系膜细胞增殖中的作用及作用其机制。方法将细胞分为正常对照组(N,5.5 mmol/L葡萄糖)、高糖组(H,25 mmom/L葡萄糖)、高糖+不同浓度的非诺贝特组(FN,10、50、100μmol/L)。采用CCK-8法检测细胞增殖率,Hoechst33258染色观察细胞凋亡形态学改变,流式细胞术检测细胞周期改变,免疫细胞化学染色观察TRB3表达,Western Blot检测细胞中TRB3、P-AKT蛋白的表达。结果高糖能够诱导肾小球系膜细胞增殖(P<0.001);非诺贝特能够抑制肾小球系膜细胞增殖(P<0.001),且具有浓度依赖性。非诺贝特干预后细胞出现凋亡形态学改变;非诺贝特可以使系膜细胞发生G1/S期阻滞;正常组、高糖组胞浆有少量TRB3蛋白表达,但高糖不能促进TRB3表达增多,随着非诺贝特浓度的增加TRB3表达量增多,P-AKT表达逐渐降低。结论非诺贝特可以促进TRB3的表达;TRB3可能通过抑制AKt的磷酸化使肾小球系膜细胞发生G1/S期阻滞从而抑制其增殖。 Objective To investigate the role of TRB3 in the inhibitory effect of fenofibrate against the proliferation of glomerular mesangial cell induced by high glucose. Methods Rat glomerular mesangial cells (MCs) were cultured in the presence of 5.5 mmol/L glucose (normal control), 25 mmol/L glucose (high glucose group), or high glucose along with 10, 50, or 100 μmol/L fenofibrate. Cell counting kit-8 (CCK-8) assay was used to evaluate cell proliferation, and Hoechst 33258 staining was employed to determine chromatin distribution in the MCs. Flow cytometry was performed to analyze the cell cycle changes in different groups. The expressions of TRB3 and P-AKT in different groups were detected using immunocytochemistry and Western blotting. Results High glucose induced obvious proliferation of the MCs (P〈0.001), which was significantly inhibited by fenofibrate in a concentration-dependent manner (P〈0.001). The MCs exposed to fenofibrate presented with typical apoptotic morphologies and cell cycle arrest at G1/S phase. Low levels of TRB3 expression was detected in the normal control and high glucose groups, whereas in the 3 fenofibrate groups, TRB3 expression increased and P-AKT expression decreased as fenofibrate concentration increased. Conclusion Fenofibrate can promote TRB3 expression in rat MCs. TRB3 causes cell cycle arrest at G1/S phase by inhibiting AKT phosphorylation to result in suppressed proliferation of the MCs.
出处 《南方医科大学学报》 CAS CSCD 北大核心 2013年第3期391-396,共6页 Journal of Southern Medical University
基金 广东省博士启动基金(S2012040006903) 广东省科技计划项目(2010B030700012)
关键词 非诺贝特 肾小球系膜细胞 TRB3 AKT 细胞周期 fenofibrate glomerular mesangial cells TRB3 AKT cell cycle
  • 相关文献

参考文献17

  • 1Li L, Emmett N, Mann D, et al. Fenofibrate attenuates tubulointerstitial fibrosis and inflammation through suppression of nuclear factor-r,B and transforming growth factor-131/Smad3 in diabetic nephropathy[J]. Exp Biol Med (Maywood), 2010, 235(3): 383-91. 被引量:1
  • 2Kadian S, Mahadevan N, Balakumar P. Differential effects of low-dose fenofibrate treatment in diabetic rats with early onset nephropathy and established nephropathy[J]. Eur J Pharmacol,2013, 698(1-3): 388-96. 被引量:1
  • 3Bishnoi HK, Mahadevan N, Balakumar P. The combined strategy with PPARct agonism and AT receptor antagonism is not superior relative to their individual treatment approach in preventing the induction of nephropathy in the diabetic rat [J]. Pharmacol Res, 2012, 66(4): 349-56. 被引量:1
  • 4Kono K, Kamijo Y, Hora K, et al. PPAR{alpha} attenuates the proinflammatory response in activated mesangial cells [J]. Am J Physiol Renal Physiol, 2009, 296(2): F328-36. 被引量:1
  • 5Ai M, Yoshida M. Fenofibrate intervention and event lowering in diabetes (FIELD) study [J]. Nihon Rinsho, 2010, 68 Suppl 9(9): 285-90. 被引量:1
  • 6mayumi-Matsuda K, Kojima S, Suzuki H, et al. Identification of a novel kinase-like gene induced during neuronal cell death [J]. Biochem Biophys Res Commun, 1999, 258: 260-4. 被引量:1
  • 7Selim E, Frkanec JT, Cunard R. Fibrates upregulate TRB3 in lymphocytes independent of PPAR alpha by augmenting CCAAT/ enhancer-binding protein beta (C/EBP beta) expression [J]. Mol Immunol, 2007, 44(6): 1218-29. 被引量:1
  • 8倪连松,金洁娜,郑景晨,沈飞霞.非诺贝特对高糖培养肾小球系膜细胞胞外基质产生及降解影响[J].温州医学院学报,2009,39(6):534-537. 被引量:3
  • 9卢宏柱,刘丹,周建华.HBV X蛋白对大鼠肾小球系膜细胞增殖及促炎性细胞因子表达的影响[J].重庆医学,2011,40(22):2227-2230. 被引量:6
  • 10王玉慧,张德伟,王沙西,梅煜明,郑红光,陈建华.IgA肾病病理特征及危险因素分析[J].中国实用内科杂志,2011,31(12):948-950. 被引量:3

二级参考文献20

  • 1Nian-SongWang,Zhao-LongWu,Yue-EZhang,Lu-TanLiao.Existence and significance of hepatitis B virus DNA in kidneys of IgA nephropathy[J].World Journal of Gastroenterology,2005,11(5):712-716. 被引量:11
  • 2孙晶,程劲.伴高血压IgA肾病患者临床病理特征[J].临床肾脏病杂志,2006,6(5):201-203. 被引量:4
  • 3王海燕.肾脏病学[M].3版.北京:人民卫生出版社,2008:8262. 被引量:481
  • 4Varghese Z, Moorhead JF, Ruan XZ. The PPARalpha ligand fenofibrate: meeting multiple targets in diabetic nephropathy [J]. Kidney Int, 2006, 69(9): 1511-1517. 被引量:1
  • 5Koya D, Haneda M, Nakagawa H, et al. Amelioration of accelerated diabetic mesangial expansion by treatment with a PKC beta inhibitor in diabetic db/db mice, a rodent model for type 2 diabetes[J]. FASEB J, 2000, 14(3): 439-447. 被引量:1
  • 6Park IS, Kiyomoto H, Abboud SL, et al. Expression of transforming growth factor-beta and type IV collagen in early treptozotocin-induced diabetes [J]. Diabetes, 1997, 46(3): 473-480. 被引量:1
  • 7Border WA, Noble NA. Evidence that TGF-beta should be a therapeutic target in diabetic nephropathy[J]. Kidney Int, 1998,54(4): 1390-1391. 被引量:1
  • 8Staels B, Fruchart JC. Therapeutic roles of peroxisome proliferator-activated receptor agonists [J]. Diabetes, 2005, 54:2460-2470. 被引量:1
  • 9Park CW, Kim HW, Ko SH, et al. Accelerated diabetic nephropathy in mice lacking the peroxisome proliferator-activated receptor alpha [J]. Diabetes, 2006, 55(4):885-893. 被引量:1
  • 10Park CW, Zhang Y, Zhang X, et al. PPARalpha agonist fenofibrate improves diabetic nephropathy in db/db mice [J]. Kidney Int, 2006, 69(9):1490-1491. 被引量:1

共引文献9

同被引文献27

引证文献4

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部